IFM-514-treated NASH ApoE-/- mice had similar circulating IL-1β and IL-1α as vehicle-treated NASH ApoE-/- mice (Figures 2D,E). This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.